11/10/2011 11:34:14
Nobel Prize and the Immune System
Isconova is delighted that this year’s Nobel Prize in Physiology or Medicine highlights central cornerstones of adjuvanticity, i.e. the impact of innate immunity and the role of dendritic cells. Congratulations to late Professor Ralph M. Steinman, Professor Bruce A. Beutler and Dr. Jules A. Hoffmann from Isconova.
12/09/2011 13:00:00
Positive T-cell data with Isconova’s Matrix M™ in avian flu vaccine study
Today members of the PanFluVac consortium presented a poster with results from an avian flu vaccine study revealing strong T-cell data with Isconovas Matrix M™ at the European Scientific Working group on Influenza (ESWI) conference in Malta September 11-14. The phase I clinical PanFluVac study evaluated the safety and the immunogenicity of an avian flu vaccine adjuvanted with Matrix M™.
05/07/2011 14:32:58
Annual Report 2010
Isconovas Annual Report 2010 is available in English.
27/04/2011 17:07:14
Editorial published in Expert Reviews
Iscom technology-based Matrix M™ adjuvant: success in future vaccines relies on formulation - Karin Lövgren Bengtsson, Bror Morein, Albert DME Osterhaus
30/03/2011 14:45:43
News
Article published in UU Innovation magazine
24/02/2011 09:34:59
Meet Isconova
During March 2011 Isconova will be presenting the company at several events. 21st of March Isconova will participate in the Life Science Investment Day Scandinavia 2011 organised by SwedenBIO. This meeting will be in English. In addition Isconova will also participate in the following Swedish language meetings: Stockholm Corporate Finance Life Science/Health Care Day 2011 in Stockholm March 9 and Stora Aktie- och Fonddagen i Uppsala 2011 March 22 which is a meeting organisered by the Swedish Shareholders’ Association.